JM, H., VR, R., KA, S., V, S., R, S., A, S., . . . AM, C. (2012). Complement C3 is a novel plasma clot component with anti-fibrinolytic properties. Diabetes & vascular disease research, 9(3), 216. https://doi.org/10.1177/1479164111432788
Chicago Style (17th ed.) CitationJM, Howes, et al. "Complement C3 Is a Novel Plasma Clot Component with Anti-fibrinolytic Properties." Diabetes & Vascular Disease Research 9, no. 3 (2012): 216. https://doi.org/10.1177/1479164111432788.
MLA (9th ed.) CitationJM, Howes, et al. "Complement C3 Is a Novel Plasma Clot Component with Anti-fibrinolytic Properties." Diabetes & Vascular Disease Research, vol. 9, no. 3, 2012, p. 216, https://doi.org/10.1177/1479164111432788.
Warning: These citations may not always be 100% accurate.
